United States: Biosimilars Webinars: A Five-Part Legal And Regulatory Issues Series
Last Updated: January 6 2016

Mintz Levin is running a series of webinars to educate our clients and friends on developments in the biosimilars space. A cross-practice team of professionals from the IP, Health and Litigation sections are collaborating to present on Patent Prosecution, Health Regulatory, FDA, Patent Litigation, Transactional and Products Liability issues. Anyone working in the biotechnology space, as well as pharmacy payors and health care providers who may be administering or dispensing biosimilars to their patients, will be interested in these presentations. The first webinar on January 7, 2016 will provide a legal and regulatory overview of the biosimilars industry and will feature Terri Shieh-Newton, PhD, and Joanne Hawana.

Subsequent presentations:

Part II: FDA/Regulatory — January 28 | 3:00 pm ET

Part III: BPCIA Patent Litigation — February 25 | 3:00 pm ET

Part IV: Transactions and Patent Portfolios — March 17 | 3:00 pm ET

Part V: Post-Market Legal and Regulatory Issues — April 7 | 3:00 pm ET

Additional Information about each of the five sessions is available here, as is a link to the registration page from which you may sign up for any or all of the seminars.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Peter Gelzinis
By Eli Greenspan, Katie Weider, Rodney Whitlock
By Natalie Young
By Joseph G. Blute, Yalonda T. Howze, Clancy Galgay
By Donald C. Davis
By Mark M. Higgins
By Michael Renaud, Adam Rizk, Jinnie L. Reed
By Mintz Levin Immigration Group
By Sahir Surmeli
By Jordan Cohen
Font Size: